AMPH: Amphastar Pharmaceuticals Inc Net Sales Margin

Graphic logo of amphastar.com (AMPH)

Amphastar Pharmaceuticals (AMPH) minimizes risks through the production of complex injectables and generics. The strategy's effectiveness is confirmed by the net profit margin, where the figure stands at 13.30. The business relies on outsourcing early-stage testing while maintaining internal control over its manufacturing plants. Revenue stability is based on demand for non-proprietary systems and strict compliance with regulatory standards across raw material supply chains.

Amphastar Pharmaceuticals (AMPH) - Net Sales Margin from 07/04/2022 to 11/19/2026

Amphastar - analytical breakdowns and key metrics (AMPH)

- market value and analyst target forecast:
Initial company analysis:Amphastar Pharmaceuticals
Finished products of Amphastar Pharmaceuticals Inc

Risks of price erosion for legacy drugs and delays in regulatory approvals for new generics directly impact the monetization efficiency of Amphastar Pharmaceuticals (AMPH) assets. An analysis of annual net margins allows for an assessment of the final profit share of revenue for each trading day, revealing whether profitability is sustainable or the result of a temporary reduction in investment expenditures for this investment asset.

Who Amphastar Pharmaceuticals competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma